Cargando…
gC1qR: A New Target for Cancer Immunotherapy
Although breakthroughs in cancer treatment have been achieved, immunotherapy yields only modest benefits in most patients. There is still a gap in clarifying the immune evasiveness and immune-resistance mechanisms. Identifying other candidate targets for cancer immunotherapy is therefore a clear unm...
Autores principales: | Lei, Yanna, Li, Xiaoyu, Qin, Diyuan, Zhang, Yugu, Wang, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909189/ https://www.ncbi.nlm.nih.gov/pubmed/36776869 http://dx.doi.org/10.3389/fimmu.2023.1095943 |
Ejemplares similares
-
Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR
por: Pednekar, Lina, et al.
Publicado: (2016) -
Microbial Protein Binding to gC1qR Drives PLA2G1B-Induced CD4 T-Cell Anergy
por: Pothlichet, Julien, et al.
Publicado: (2022) -
gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma
por: Peerschke, Ellinor, et al.
Publicado: (2020) -
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma
por: Balduit, Andrea, et al.
Publicado: (2023) -
Structure–Function Studies Using Deletion Mutants Identify Domains of gC1qR/p33 as Potential Therapeutic Targets for Vascular Permeability and Inflammation
por: Ghebrehiwet, Berhane, et al.
Publicado: (2011)